Community pharmacies continue to operate in unchartered territory regarding Medicare drug price negotiations as the new IRA statute becomes an unavoidable reality for business operations.Moving into 2026, the Inflation Reduction Act (IRA) is officially shifting from a legislative policy to a daily reality for pharmacists. For the first time, negotiated Maximum Fair Prices (MFPs) have […]

Author